In hepatocellular carcinoma (HCC), CA inhibits the activity of GRP75 (75 KDa Glucose-Regulated Protein) induced by low doses of the carcinogen Benzo(a)pyrene (B[a]P) through both transcriptional and post-transcriptional modifications. The gene discussed is HSPA9; the disease is hepatocellular carcinoma.